Start-Up Previews (9/04)
A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile group, Addressing Alzheimer's, features profiles of Cognitive Pharmaceuticals Ltd., EnVivo Pharmaceuticals Inc., Reata Discovery Inc., Senexis Ltd. and Zapaq Inc. Plus these Start-Ups across Health Care: CoreValve SA, Lectus Therapeutics Ltd. and NeoGuide Systems Inc.
You may also be interested in...
Pembrolizumab should be considered the new standard of care as first-line therapy in patients with microsatellite instability high (MSI-H) metastatic colorectal cancer, KEYNOTE-177 investigator André said.
Amivas requested a US tropical disease PRV for intravenous artesunate but FDA has not yet made a decision on eligibility; approval appears to block La Jolla’s competing product, currently under review, for seven years.
In a pair of guidance documents the US agency explains clearance options and its enforcement policy for sponsors of devices used to reduce contaminants in COVID-19 masks and respirators.